Heidelberg Pharma AG (HPHA) — Financial Flexibility Index

Latest as of May 2025: -0.13x

Heidelberg Pharma AG (HPHA) has a Financial Flexibility Index of -0.13x as of May 2025. Free cash flow of €-5.53 Million (operating CF €-5.53 Million minus capex €0.00) represents 0% of total liabilities (€43.94 Million). Check total reinvestment intensity of Heidelberg Pharma AG to assess the company's total reinvestment commitment from operating cash flow.

Financial Flexibility Index

-0.13x
Free Cash Flow / Total Liabilities

Free Cash Flow

€-5.53 Million
Operating CF − Capex

Total Liabilities

€43.94 Million
EUR

Capital Expenditures

€0.00
EUR

Heidelberg Pharma AG Financial Flexibility Index (2016–2024)

Historical Financial Flexibility Index trend for Heidelberg Pharma AG across 9 annual periods. For the full cash flow conversion analysis, see HPHA cash generation efficiency.

Annual Financial Flexibility Index for Heidelberg Pharma AG (2016–2024)

Year-by-year free cash flow to debt coverage for Heidelberg Pharma AG. Explore Heidelberg Pharma AG (HPHA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (EUR) Operating CF Total Liabilities YoY Change
2024 -0.98x €-29.11 Million €-29.59 Million €29.85 Million ▲ +37.4%
2023 -1.56x €-32.71 Million €-33.67 Million €21.01 Million ▼ -540.3%
2022 -0.24x €-8.25 Million €-8.86 Million €33.94 Million ▲ +85.6%
2021 -1.69x €-25.37 Million €-26.61 Million €15.03 Million ▲ +31.3%
2020 -2.46x €-16.52 Million €-17.89 Million €6.73 Million ▼ -114.8%
2019 -1.14x €-7.65 Million €-8.56 Million €6.70 Million ▲ +32.7%
2018 -1.70x €-9.01 Million €-9.98 Million €5.31 Million ▼ -0.6%
2017 -1.69x €-7.54 Million €-7.94 Million €4.47 Million ▼ -54.4%
2016 -1.09x €-6.00 Million €-6.53 Million €5.49 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities